HEPA · Hepion Pharmaceuticals, Inc. · Exempt Offerings
$0.14
-0.18 (-57.55%)
At close · May 13
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.77M
Shares
90.22M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-08-05 | New | Biotechnology | $3,055,000 | $3,055,000 | 06b |
| 2026-04-22 | New | Biotechnology | $700,000 | $700,000 | 06b |
| 2024-07-24 | New | Pharmaceuticals | $2,900,000 | $2,900,000 | 06b |
| 2023-10-03 | New | Pharmaceuticals | $5,000,004 | $5,000,004 | 06b |
| 2022-11-15 | New | Biotechnology | $20,000,000 | $20,000,000 | 06b |
Showing 1–5 of 5 filings